| Table 1. | Stages of Chronic Kidney Disease |
| Table 2. | Major Features of Abnormalities in Mineral Metabolism in Kidney Failure |
| Table 3. | Factors Affecting the Level of Serum Phosphorus in CKD |
| Table 4. | Biological Consequences of Vitamin D Deficiency |
| Table 5. | Possible Reasons for Variations in Bone Disease Among Patients with Chronic Kidney Disease |
| Table 6. | Factors That May Predispose to Soft-Tissue Calcification in Stages 4 and 5 CKD |
| Table 7. | Steps Used to Develop the Bone Disease Guidelines |
| Table 8. | Summary of Article Retrievals |
| Table 9. | Evidence Base for Evidence Reports |
| Table 10. | Rating of Methodological Quality |
| Table 11. | Rating of Applicability |
| Table 12. | Example of a Study Quality Overview Table |
| Table 13. | Grading Rationale Statements |
| Table 14. | Frequency of Measurement of PTH and Calcium/Phosphorus by Stage of CKD |
| Table 15. | Target Range of Intact Plasma PTH by Stage of CKD |
| Table 16. | Factors Prevalent in CKD Patients Which May Influence the Type of Osteodystrophy Lesion |
| Table 17. | Non–CKD-Related Factor Which May Affect Bone Metabolism in CKD Patients |
| Table 18. | Pathologies Identified by Bone Biopsy Measures |
| Table 19. | Side Effects Associated with a Phosphorus-Restricted Diet and Their Rate of Occurrence |
| Table 20. | Phosphorus Content of Protein-Containing Foods |
| Table 21. | Steps To Calculate the Initial Binder Prescription |
| Table 22. | Phosphorus-Binding Compounds |
| Table 23. | Adequate and Upper Intake Levels of Calcium for Healthy People by Age |
| Table 24. | Calcium Content of Common Calcium-Based Binders |
| Table 25. | Factorial Analysis for Determining Calcium Requirements in Adults Aged 19-30 Years |
| Table 26. | Recommended Supplementation for Vitamin D Deficiency/Insufficiency in Patients with CKD Stages 3 and 4 |
| Table 27. | Serum Levels of PTH, Calcium and Phosphate Required for Initiation of Oral Vitamin D Sterol Therapy, and Recommended Initial Doses in Patients with Stages 3 and 4 CKD |
| Table 28. | Recommended Initial Dosing for Vitamin D Sterols by Serum Levels of Intact PTH, Calcium, Phosphorus, and Ca-P Product |
| Table 29. | Effect of Dialysis Membranes on the Development of Clinical or Radiographic Symptoms of β2-Microglobulin Amyloidosis |
| Table 30. | Summary of the Results of the Effect of Different Dialysis Membranes on β2-Microglobulin Serum Levels |
| Table 31. | Aluminum-Related Disorders: Features, Causes and Considerations for Therapy |
| Table 32. | Frequency for Measurement of Serum Levels of Total CO2 |
| Table 33. | Frequency of Measurement of Calcium, Phosphorus, PTH and Total CO2 after Kidney Transplantation |
| Table 34. | Commercially Available Preparations for Phosphate Supplementation |